Latest Trading Updates News

Super Retail Group updates key sales growth figures while outlining increased costs from system upgrades and distribution centre transitions, signaling a cautious outlook amid mixed retail conditions.

Super Retail Group reports a 3.1% like-for-like sales growth in H2 FY25, driven by key brands and strategic investments in its omni-retail network and supply chain.

Super Retail Group reports steady sales growth driven by BCF and rebel brands, while facing increased costs from a new distribution centre and HR system upgrades.

Kelsian Group signals a cautious FY25 outlook with EBITDA tracking at the lower end of guidance, while advancing strategic tourism divestments and securing key contract renewals.

Temple & Webster reports a strong trading update with revenue growth accelerating to 23% since March and a positive EBITDA margin outlook for FY25, despite ongoing economic headwinds.

Nine Entertainment reports solid Q3 advertising revenue growth and cost efficiencies while advancing a major stake sale in Domain, positioning the media giant for strategic expansion.

Nuix Limited has withdrawn its FY25 growth targets due to unpredictable timing in closing large deals, despite maintaining a strong pipeline and confidence in its strategic direction.

Inghams Group Limited confirms its FY25 outlook with a slight decline in core poultry volumes offset by modest price increases and new business gains.

Sigma Healthcare’s recent merger with Chemist Warehouse Group is delivering strong earnings growth, with Normalised EBIT rising 36% in the first half of FY25. Transaction costs remain significant but the combined group’s outlook appears robust.

Boom Logistics reports robust 3Q FY25 results with revenue and profit gains led by renewables projects, while pausing its share buy-back after meeting targets.

Endeavour Group reports a challenging Q3 with Retail sales down 3.1% and Hotels up 5.1%, while announcing Jayne Hrdlicka as incoming CEO and maintaining capital and finance guidance.

Gale Pacific has sharply downgraded its full-year EBITDA guidance due to tariff-driven demand softness in the US, while its Australia, New Zealand, and developing markets hold steady.